| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.061 | 0.2 |